8 research outputs found
Lupin protein isolate versus casein modifies cholesterol excretion and mRNA expression of intestinal sterol transporters in a pig model
Abstract
Background
Lupin proteins exert hypocholesterolemic effects in man and animals, although the
underlying mechanism remains uncertain. Herein we investigated whether lupin proteins
compared to casein modulate sterol excretion and mRNA expression of intestinal sterol
transporters by use of pigs as an animal model with similar lipid metabolism as humans, and
cellular cholesterol-uptake by Caco-2 cells.
Methods
Two groups of pigs were fed cholesterol-containing diets with either 230 g/kg of lupin
protein isolate from L. angustifolius or 230 g/kg casein, for 4 weeks. Faeces were collected
quantitatively over a 5 d period for analysis of neutral sterols and bile acids by gas
chromatographically methods. The mRNA abundances of intestinal lipid transporters were
analysed by real-time RT-PCR. Cholesterol-uptake studies were performed with Caco-2 cells
that were incubated with lupin conglutin \u3b3, phytate, ezetimibe or albumin in the presence of
labelled [4-14C]-cholesterol.
Results
Pigs fed the lupin protein isolate revealed lower cholesterol concentrations in total plasma,
LDL and HDL than pigs fed casein (P < 0.05). Analysis of faeces revealed a higher output of
cholesterol in pigs that were fed lupin protein isolate compared to pigs that received casein
(+57.1%; P < 0.05). Relative mRNA concentrations of intestinal sterol transporters involved
in cholesterol absorption (Niemann-Pick C1-like 1, scavenger receptor class B, type 1) were
lower in pigs fed lupin protein isolate than in those who received casein (P < 0.05). In vitro
data showed that phytate was capable of reducing the uptake of labelled [4-14C]-cholesterol
into the Caco-2 cells to the same extend as ezetimibe when compared to control ( 1220.5% vs.
1221.1%; P < 0.05).
Conclusions
Data reveal that the cholesterol-lowering effect of lupin protein isolate is attributable to an
increased faecal output of cholesterol and a reduced intestinal uptake of cholesterol. The
findings indicate phytate as a possible biofunctional ingredient of lupin protein isolate.Background: Lupin proteins exert hypocholesterolemic effects in man and animals, although the underlying mechanism remains uncertain. Herein we investigated whether lupin proteins compared to casein modulate sterol excretion and mRNA expression of intestinal sterol transporters by use of pigs as an animal model with similar lipid metabolism as humans, and cellular cholesterol-uptake by Caco-2 cells. Methods. Two groups of pigs were fed cholesterol-containing diets with either 230 g/kg of lupin protein isolate from L. angustifolius or 230 g/kg casein, for 4 weeks. Faeces were collected quantitatively over a 5 d period for analysis of neutral sterols and bile acids by gas chromatographically methods. The mRNA abundances of intestinal lipid transporters were analysed by real-time RT-PCR. Cholesterol-uptake studies were performed with Caco-2 cells that were incubated with lupin conglutin \u3b3, phytate, ezetimibe or albumin in the presence of labelled [4- 14C]-cholesterol. Results: Pigs fed the lupin protein isolate revealed lower cholesterol concentrations in total plasma, LDL and HDL than pigs fed casein (P < 0.05). Analysis of faeces revealed a higher output of cholesterol in pigs that were fed lupin protein isolate compared to pigs that received casein (+57.1%; P < 0.05). Relative mRNA concentrations of intestinal sterol transporters involved in cholesterol absorption (Niemann-Pick C1-like 1, scavenger receptor class B, type 1) were lower in pigs fed lupin protein isolate than in those who received casein (P < 0.05). In vitro data showed that phytate was capable of reducing the uptake of labelled [4- 14C]-cholesterol into the Caco-2 cells to the same extend as ezetimibe when compared to control (-20.5% vs. -21.1%; P < 0.05). Conclusions: Data reveal that the cholesterol-lowering effect of lupin protein isolate is attributable to an increased faecal output of cholesterol and a reduced intestinal uptake of cholesterol. The findings indicate phytate as a possible biofunctional ingredient of lupin protein isolate
Dietary protein intake and health-related outcomes: a methodological protocol for the evidence evaluation and the outline of an evidence to decision framework underlying the evidence-based guideline of the German Nutrition Society
PURPOSE: The present work aimed to delineate (i) a revised protocol according to recent methodological developments in evidence generation, to (ii) describe its interpretation, the assessment of the overall certainty of evidence and to (iii) outline an Evidence to Decision framework for deriving an evidence-based guideline on quantitative and qualitative aspects of dietary protein intake. METHODS: A methodological protocol to systematically investigate the association between dietary protein intake and several health outcomes and for deriving dietary protein intake recommendations for the primary prevention of various non-communicable diseases in the general adult population was developed. RESULTS: The developed methodological protocol relies on umbrella reviews including systematic reviews with or without meta-analyses. Systematic literature searches in three databases will be performed for each health-related outcome. The methodological quality of all selected systematic reviews will be evaluated using a modified version of AMSTAR 2, and the outcome-specific certainty of evidence for systematic reviews with or without meta-analysis will be assessed with NutriGrade. The general outline of the Evidence to Decision framework foresees that recommendations in the derived guideline will be given based on the overall certainty of evidence as well as on additional criteria such as sustainability. CONCLUSION: The methodological protocol permits a systematic evaluation of published systematic reviews on dietary protein intake and its association with selected health-related outcomes. An Evidence to Decision framework will be the basis for the overall conclusions and the resulting recommendations for dietary protein intake
Zum Einfluss von Cholesterin, Fischoel und anderen Nahrungslipiden auf Parameter des Lipidstoffwechsels von Ratten
Die Konz. der Lipide im Serum und in den Lipoproteinen wurden durch alle untersuchten Nahrungslipide (Fischoel, Olivenoel, Disteloel, Nachtkerzenoel, Leinoel) sowie die atherogene Diaet (AT, hohe Mengen gesaettigtes Fett sowie Cholesterin) erheblich beeinflusst. Die Fettsaeuren-Zusammensetzung (FSZ) der Leber veraenderte sich durch Cholesterin (CH), Fischoel und andere Nahrungslipide stark, die des Gehirns nur wenig, die der Erythrozytenmembran und die Haemolyseresistenz der Erythrozyten wurde beeinflusst. AT sowie blosse Zulagen von CH erhoehten die Aktivitaet von GOT und GPT sowie die Konz. des Kreatinins und Gesamtproteins im Serum. Polyenfettsaeuren (n-6, n-3) senkten die GOT-Aktivitaet, Fischoel verringerte auch die Konz. des Gesamtproteins, Albumins und Kreatinins im Serum. Die anderen Oele beeinflussten kaum das Serim-ProteinSIGLEAvailable from: D-80333 Muenchen Technische Univ. (Germany). Universitaetsbibliothek, Arcisstr. 21 / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekDEGerman
Global Burden of Sugar-Related Dental Diseases in 168 Countries and Corresponding Health Care Costs
Longitudinal trends of serum IgE and IL5RA expression throughout childhood are associated with asthma but not with persistent wheeze.
Dietary protein and blood pressure: an umbrella review of systematic reviews and evaluation of the evidence
INTRODUCTION: This umbrella review aimed to investigate the evidence of an effect of dietary intake of total protein, animal and plant protein on blood pressure (BP), and hypertension (PROSPERO: CRD42018082395). METHODS: PubMed, Embase and Cochrane Database were systematically searched for systematic reviews (SRs) of prospective studies with or without meta-analysis published between 05/2007 and 10/2022. The methodological quality and outcome-specific certainty of evidence were assessed by the AMSTAR 2 and NutriGrade tools, followed by an assessment of the overall certainty of evidence. SRs investigating specific protein sources are described in this review, but not included in the assessment of the overall certainty of evidence. RESULTS: Sixteen SRs were considered eligible for the umbrella review. Ten of the SRs investigated total protein intake, six animal protein, six plant protein and four animal vs. plant protein. The majority of the SRs reported no associations or effects of total, animal and plant protein on BP (all "possible" evidence), whereby the uncertainty regarding the effects on BP was particularly high for plant protein. Two SRs addressing milk-derived protein showed a reduction in BP; in contrast, SRs investigating soy protein found no effect on BP. The outcome-specific certainty of evidence of the SRs was mostly rated as low. DISCUSSION/CONCLUSION: This umbrella review showed uncertainties whether there are any effects on BP from the intake of total protein, or animal or plant proteins, specifically. Based on data from two SRs with milk protein, it cannot be excluded that certain types of protein could favourably influence BP